Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes
Boca Raton, FL (PRWEB) May 29, 2015 -- Wimbledon Health Partners, the leading on-site diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram and NCV testing, is proud to announce the implementation of the most recent guidelines for EKG interpretation of athletes.
Sudden cardiac death (SCD) is the leading cause of death during athletic activity. New findings presented in February have played an important role in the continued discussion to improve cardiac safety in athletes. Physiologic adaptations in athletic individuals are well known to have effects on cardiac electrical conduction.
The ‘Seattle Criteria,’ encourages physicians responsible for the cardiovascular care of athletes to be guided by EKG interpretation standards that distinguish normal EKG findings in athletes from EKG abnormalities requiring additional evaluation to reduce the likelihood of false-positives. In 2013, the presented criteria reduced the frequency of false-positive EKG readings in athletes from 20 percent down to 5 percent, and the most recent criteria, improved that rate to 4 percent.
“Opponents of EKG exams have always cited the previously high false-positive rate when disputing the implementation of mandatory testing of student-athletes,” said Dr. Artel, M.D., F.A.C.C., Chief Medical Officer at Wimbledon Health Partners, “The utilization of
the 'Seattle Criteria' has now decreased that rate to the point where this argument is inconsequential.”
Wimbledon Athletics teams up with high schools, amateur sport associations, and any other athletic organizations nationwide that want to assess the heart health of their athletes. Wimbledon U, exclusively offers colleges and universities on-site comprehensive cardiac testing. For more information, or to learn how to bring on-site diagnostic testing to your team, please call (855) 200-8262 or visit http://www.dxtesting.com.
About Wimbledon Health Partners:
Wimbledon Health Partners was formed in response to the demand to attain on-site diagnostic testing capabilities for circulatory conditions that can be detected through the use of vascular ultrasound and echocardiography. Furthering our capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. The company also reinforces its mission of promoting early testing through its athletics testing division, Wimbledon Athletics, specifically focusing on underlying symptoms related to arterial diseases to help minimize death among young athletes. Wimbledon Health Partners is an innovative cooperative marketing and practice-enhancement program that provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. For more information go to http://www.dxtesting.com or call (855) 200-8262.
Meredith Troy, Wimbledon Health Partners, http://www.dxtesting.com, +1 855-200-8262, [email protected]
Share this article